NDC 55289-920-98
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-98
- Package NDCs from labels
- 55289-920-98
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chlordiazepoxide Hydrochloride | CHLORDIAZEPOXIDE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3cbd7cee-c4d7-4c95-93d8-09428169b937 | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Phentermine Hydrochloride | PHENTERMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e4508aa9-1e7a-4af7-829e-5fa353c92f5e | 2025-08-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 67bedecc-f758-4bc6-82c5-7d428cbbbd9b | 2025-08-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2025-08-18 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | b4c7388a-19d9-4e3a-83c9-4943fb855be4 | 2025-08-18 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 48d8f490-e9d1-4c95-ab2f-414d3f4a9df4 | 2025-08-18 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 473d90ed-e262-4ec6-975b-494d89f1ad70 | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2b05bd0e-af57-4e74-92f8-a4311330142f | 2025-08-18 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 214b3f14-2f6c-4f36-b7a6-e0b1f820e3a7 | 2025-08-18 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | c24489c3-65e0-44e3-a50a-8bb0672e8821 | 2025-08-15 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 52e75604-5766-40e8-a13a-8c449e06ebda | 2025-08-15 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 12137a90-fb35-45d7-8984-0b04793d3e34 | 2025-08-15 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 426ba54f-199a-41d1-8c27-f827bea56854 | 2025-08-15 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3c611c8c-deed-4904-93f7-f75a2147fbf7 | 2025-08-14 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2025-08-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Clarithromycin | CLARITHROMYCIN | PD-Rx Pharmaceuticals, Inc. | ba216276-b0bd-420a-9e0d-090bdfcc2460 | 2025-08-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | 615dfd5c-125a-40e2-a6da-afacde305282 | 2025-07-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ursodiol | URSOSIOL | PD-Rx Pharmaceuticals, Inc. | d89c9e1e-a115-4a01-9275-74d6cd8cf285 | 2025-07-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| PredniSONE | PREDNISONE | PD-Rx Pharmaceuticals, Inc. | f4500eb6-d24a-4247-83f4-99e73346e328 | 2025-07-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.